Isacson R - Search Results

1

Abdominal cocoon: a potential pitfall in patients with ovarian carcinoma.

Isacson R, Segal A, Alberton J, Reinus C, Schwarz A, Grenader T. Isacson R, et al. Tumori. 2012 Nov;98(6):176e-8e. doi: 10.1700/1217.13517. Tumori. 2012. PMID: 23389380

2

Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin.

Grenader T, Rosengarten O, Isacson R, Plotkin Y, Gabizon A. Grenader T, et al. Among authors: isacson r. World J Clin Oncol. 2012 Oct 10;3(10):137-41. doi: 10.5306/wjco.v3.i10.137. World J Clin Oncol. 2012. PMID: 23198277 Free PMC article.

3

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival.

Tahover E, Segal A, Isacson R, Rosengarten O, Grenader T, Gips M, Cherny N, Heching NI, Mesika L, Catane R, Gabizon A. Tahover E, et al. Among authors: isacson r. Anticancer Drugs. 2017 Aug;28(7):787-794. doi: 10.1097/CAD.0000000000000514. Anticancer Drugs. 2017. PMID: 28562379

4

Cancer patient expectations of and communication with oncologists and oncology nurses: the experience of an integrated oncology and palliative care service.

Sapir R, Catane R, Kaufman B, Isacson R, Segal A, Wein S, Cherny NI. Sapir R, et al. Among authors: isacson r. Support Care Cancer. 2000 Nov;8(6):458-63. doi: 10.1007/s005200000163. Support Care Cancer. 2000. PMID: 11094990

5

A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma.

Lowery M, Shah MA, Smyth E, Epstein A, Segal A, Rosengarten O, Isacson R, Drukker L, Keinan A, Rachkiman M, Reissman P, Gabizon A, Kelsen D, O'Reilly EM. Lowery M, et al. Among authors: isacson r. J Gastrointest Cancer. 2011 Sep;42(3):160-4. doi: 10.1007/s12029-010-9197-1. J Gastrointest Cancer. 2011. PMID: 20711688

6

Scintigraphic evaluation of patients with thyroid carcinoma--therapeutic approaches.

Krausz Y, Uziely B, Lijovetsky G, Isacson R, Levinger E, Catane R, Karger H, Atlan H. Krausz Y, et al. Among authors: isacson r. Isr J Med Sci. 1992 Mar-Apr;28(3-4):206-11. Isr J Med Sci. 1992. PMID: 1592589

7

Recurrence-associated mortality in patients with differentiated thyroid carcinoma.

Krausz Y, Uziely B, Karger H, Isacson R, Catane R, Glaser B. Krausz Y, et al. Among authors: isacson r. J Surg Oncol. 1993 Mar;52(3):164-8. doi: 10.1002/jso.2930520309. J Surg Oncol. 1993. PMID: 8441273

8

A preliminary report of a pilot randomized trial comparing cyclophosphamide, methotrexate and 5-fluorouracil with cyclophosphamide, mitoxantrone and 5-fluorouracil in the adjuvant therapy of stage II breast cancer with four or more positive axillary nodes.

Isacson R, Safra T, Ben-Dor CG, Uziely B, Brufman G. Isacson R, et al. Anticancer Drugs. 1993 Apr;4(2):189-92. doi: 10.1097/00001813-199304000-00009. Anticancer Drugs. 1993. PMID: 8490197 Clinical Trial.

9

Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer.

Sulkes A, Gez E, Pfeffer MR, Catane R, Isacson R, Biran S. Sulkes A, et al. Among authors: isacson r. Cancer Chemother Pharmacol. 1986;18(2):162-7. doi: 10.1007/BF00262288. Cancer Chemother Pharmacol. 1986. PMID: 3791561

10

Clinical studies of liposome-encapsulated doxorubicin.

Gabizon A, Isacson R, Libson E, Kaufman B, Uziely B, Catane R, Ben-Dor CG, Rabello E, Cass Y, Peretz T, et al. Gabizon A, et al. Among authors: isacson r. Acta Oncol. 1994;33(7):779-86. doi: 10.3109/02841869409083948. Acta Oncol. 1994. PMID: 7993646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters